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A B S T R A C T
The mitochondrial human proteome project (mt-HPP) was initiated by the Italian HPP group as a part of
both the chromosome-centric initiative (C-HPP) and the “biology and disease driven” initiative (B/D-
HPP). In recent years several reports highlighted how mitochondrial biology and disease are regulated by
speciﬁc interactions with non-mitochondrial proteins. Thus, it is of great relevance to extend our present
view of the mitochondrial proteome not only to those proteins that are encoded by or transported to
mitochondria, but also to their interactors that take part in mitochondria functionality. Here, we propose
a graphical representation of the functional mitochondrial proteome by retrieving mitochondrial
proteins from the NeXtProt database and adding to the network their interactors as annotated in the
IntAct database. Notably, the network may represent a reference to map all the proteins that are currently
being identiﬁed in mitochondrial proteomics studies.
ã 2016 The Authors. Published by Elsevier B.V. on behalf of European Proteomics Association (EuPA). This
is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).
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journal home page: www.elsevier .com/ locat e/euprotThe Human Proteome Organization (HUPO) has promoted in
recent years a concerted action aimed at the full characterization of
the human proteome. Two measures have been put forward in
parallel. First, the chromosome-centric initiative (C-HPP) aimed at
joining the efforts of several groups with a country-based strategy
to unravel the human proteome to reduce to a minimum, and
possibly to eliminate, the number of proteins that did not show
evidence at the protein level in the dedicated database such as
NeXtProt [1,2]. Second, the “biology and disease driven” initiative
(B/D-HPP) aimed at functional clustering of proteins around a
signiﬁcant biological issue [3]. To address some of these gaps,
several consortia were formed, focusing on the human eye, diabetes,
pediatric diseases, liver, brain, cancer, infectious diseases, autoim-
mune disorders, epigenetics, among others. A great contribution to
these initiatives was provided by the technological pillars: the
Human Proteome Atlas (HPA), the bioinformatics, and the mass
spectrometry technological advancement study groups [4].
The two HPP programs are strongly intersected; in fact, the
effort to consolidate the current available tools to identify and* Corresponding author. Fax: +39 0332 395599.
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(http://creativecommons.org/licenses/by-nc-nd/4.0/).quantify all the genome-encoded proteins is providing the
fundamental framework to highlight novel molecular targets for
the B/D efforts. The Italian HPP group did a great effort in bringing
laboratories across the globe to take part in the Italian Proteomics
Association (ItPA) project to unravel the mitochondrial human
proteome project (mt-HPP) as part of both C-HPP and B/D-HPP
initiatives [5].
Mitochondria are essential organelles for the life and death of
cells, and several human disorders are associated to mitochondrial
dysfunction. While some human diseases are strictly linked to
mutations in the mitochondrial genome, many others are
someway connected to mitochondrial functionality by defects in
the sequence of proteins encoded by nuclear chromosomes that
are imported into mitochondria through their mitochondrial
transfer sequence (MTS) [6]. Mutations of cytosolic proteins that
regulate the elimination of impaired mitochondria segregate with
severe degenerative disorders, such as Parkinson’s disease. For
instance, a number of mutations in the PARK2, PINK1 and
PARK7 genes have been shown to cause mitochondrial parkinson-
ism [7], although PARK2 and PARK7 gene products (parkin and DJ-
1, respectively) do not belong, strictly speaking, to the mitochon-
drial proteome, as they are not imported into mitochondria. In fact,
several recent reports highlighted the relevance of cytosolicics Association (EuPA). This is an open access article under the CC BY-NC-ND license
Fig. 2. The mitochondrial human proteome from a functional perspective. Cyan
nodes represent proteins encoded by the mitochondrial genome or translocated to
the mitochondrion. Protein identities were obtained by querying the NeXtProt
database. Red nodes represent interactors of the cyan nodes as obtained by querying
the IntAct database using the PSICQUIC query module embedded in Cytoscape.
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tures in the governance of mitochondrial functions. Although
mitochondria are usually associated to their role in cellular
energetics, they exert a number of functions that are not conﬁned
to ATP production. In particular, calcium ion homeostasis is
regulated by a strict functional and spatial connection between
mitochondria and the endoplasmic reticulum, and glycolysis has
been shown to be coupled to ATP production through the spatial
recognition of the glycolytic enzyme hexokinase by the outer
membrane porin VDAC1 [8–10].
In recent years, several papers underlined the role of
mitophagy, the disposal of dysfunctional mitochondria by the
autophagic machinery on a whole-cell level. Parkin and
PINK1 assumed a fundamental role in targeting mitochondria to
the autophagosome through ubiquitination of outer surface
membrane proteins, although this mechanism still seems to be
controversial [11,12]. Additionally, the maintenance of a well-
organized mitochondrial network was shown to be a peculiar actor
in assuring full functionality of the mitochondrion [13]. To this
purpose, a thorough assessment of the mitochondrial interactome
should ﬁll the gaps in our knowledge of the complex biological
processes sustained by the mitochondrial proteome [14,15].
It is of great relevance to extend our present view of the
mitochondrial proteome not only to those proteins that are
encoded by the mitochondrial or nuclear genomes, but also to their
interactors that take part in mitochondrial functionality, mainte-
nance, dynamics and metabolism [16]. Thus, the integration of
information obtained within the C-HPP and B/D-HPP actions with
interactomics data deposited in the IntAct database [17] and
protein annotation in the NeXtProt database is a priority (Fig. 1). To
date, 13 proteins are listed in the NeXtProt database (September
2015 release) as mitochondrial-encoded, whereas another
1869 proteins were annotated as mitochondrial proteins. AmongFig.1. A functional deﬁnition of the human mitochondrial proteome requires the integrat
a full coverage of the human proteome by C-HPP; protein evidence and functional annotthem,1277 entries were indicated to be evident at the protein level,
with 592 remaining missing proteins. A search in the IntAct
database allowed us to identify a broad panel of interactors thation of several efforts. From top-left, clockwise: functional studies from the B/D-HPP;
ation in the NeXtProt database; interactomics annotation from the IntAct database.
Fig. 3. Segmentation of the mitochondrial proteome network. Subnetworks were obtained by clusterMaker (Cytoscape app) using the GLay algorithm. Over-represented
pathways (Reactome) are: A, protein synthesis; B, oxidative phosphorylation; C, energy metabolism; D, apoptosis and mitophagy; E, RNA synthesis and processing; F,
signaling by EGFR; G, protein trafﬁcking; H, MAPK signaling pathway; I, WNT signaling; J, Nucleotide excision repair; K, mRNA decay; L, vesicle trafﬁcking; M, Sema3A
signaling. Cyan nodes represent proteins encoded by the mitochondrial genome or translocated to the mitochondrion, whereas red nodes represent their interactors.
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the mitochondrial human proteome. Fig. 2 shows a graph
representation of this concept, with proteins encoded by or
translocated into the mitochondrion represented as cyan spots and
non-mitochondrial interactors as red spots. It appears evident,
therefore, that the large majority of the 6592 nodes in the proposed
network do not belong to the mitochondrial proteome, although
they deeply inﬂuence mitochondrial biology.
Due to its complexity, the mitochondrial human proteome in its
enlarged, functional view needs to be segmented into subnet-
works. Network clustering helps the identiﬁcation of enriched
pathways where mitochondrial complexes play a fundamental
role. Fig. 3 shows the more representative clusters obtained by
segmentation of the enlarged mitochondrial network. The large
network shown in Fig. 2 has been segmented with the cluster-
Maker Cytoscape app using the GLay algorithm [18,19]. Over-
representation analysis of each cluster for Reactome pathways [20]
may therefore deﬁne the principal biological processes where the
functional mitochondrial proteome is involved in. Most notably,
each cluster could represent a reference to map all the proteins
that are currently being identiﬁed within the mt-HPP consortium.
Furthermore, reference maps should help to aggregate all proteins
identiﬁed in interactomics investigations, where several method-
ologies are employed to connect experimentally identiﬁed preys
with any mitochondrial bait of interest. Eventually, lists of
differentially expressed proteins arising from functional/differen-
tial expression proteomics studies might be located on the wholenetwork or on any subnetwork to broaden the viewpoint of a single
focused investigation.
In summary, the mitochondrial proteome should be taken into
account as a dynamic and possibly chronosteric reality, with
signiﬁcant overlaps with the whole-cell proteome. Several efforts
should be made to unravel the contribution of any single protein to
biological processes and molecular mechanisms controlled by this
organelle and its relationship to human diseases. An audacious and
ﬂexible research consolidated by robust analytical data and
technological developments has been a fundamental actor for
the advance of the human milestones in the hypothesis driven
scenario such as the Human Genome Project [21]. Thus, the HPP
may well accept to pursue daring goals as long as overall objectives
are well grounded in a structured effort in an ardent and humble
awareness of the current technological and conceptual limitations.
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